Patients were randomly assigned @:@ to receive ipilimumab at @ mg/kg plus dacarbazine ( n = @ ) or placebo plus dacarbazine ( n = @ ) at weeks @ , @ , @ , and @ followed by dacarbazine alone every @ weeks through week @ .